Status | Study |
Terminated |
Study Name: Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer Condition: Cancer Date: 2010-05-26 Interventions: Drug: cyproheptadine hydrochloride |
Recruiting |
Study Name: Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma Condition: Glioma Neurofibromatosis Type 1 Recurrent Childhood Pilocy Date: 2010-03-17 Interventions: Other: Laboratory Biomarker Analysis |
Terminated |
Study Name: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia Condition: Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Central Nervous System Choriocarcinoma Date: 2010-03-16 Interventions: Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097 |
Completed |
Study Name: Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma Condition: Childhood Burkitt Lymphoma Childhood Central Nervous System Choriocarcinoma Date: 2009-10-10 Interventions: Drug: vorinostat Given orally |
Completed |
Study Name: Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment Condition: Childhood Central Nervous System Choriocarcinoma Childhood Central Nervous System Embryonal Date: 2009-06-27 Interventions: Drug: pazopanib hydrochloride |
Recruiting |
Study Name: Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors Condition: Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Central Nervous System Germ Cell Tumor Date: 2009-06-11 Interventions: Other: cytology specimen collection procedure Correlative studies |
Active, not recruiting |
Study Name: Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor Condition: Solid Tumor Adult Central Nervous System Germ Cell Tumor A Date: 2008-03-18 Interventions: Drug: busulfan Given IV |
Active, not recruiting |
Study Name: Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer Condition: Brain and Central Nervous System Tumors Intraocular Melanoma Date: 2007-03-07 Interventions: Genetic: DNA analysis Other: immunologic t |
Completed |
Study Name: AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors Condition: Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Central Nervous System Germ Cell Tumor Date: 2006-05-16 Interventions: Drug: Cediranib Maleate Given orally Other Names: |
Completed |
Study Name: Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas Condition: Childhood Burkitt Lymphoma Childhood Central Nervous System Germ Cell Tumor Date: 2005-01-07 Interventions: Drug: irinotecan hydrochloride |